(E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene
- $315 - $324
- Product name: (E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene
- CAS: 1620487-87-7
- MF: C76H104Si2
- MW: 1073.81
- EINECS:-0
- MDL Number:MFCD28386084
- Synonyms:(E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene;(E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene;(E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene >Disilene, 1,2-di-1-naphthalenyl-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-, (1E)-;(Eind)(1-Naph)Si=Si(1-Naph)(Eind)
2 prices
Selected condition:
Brand
- AK Scientific
- TCI Chemical
Package
- 10mg
- ManufacturerAK Scientific
- Product number4098AL
- Product description(E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-S-indacen-4-yl)disilene
- Packaging10mg
- Price$324
- Updated2021-12-16
- Buy
- ManufacturerTCI Chemical
- Product numberB4421
- Product description(E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene >70.0%(HPLC)
- Packaging10mg
- Price$315
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4098AL | (E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-S-indacen-4-yl)disilene | 10mg | $324 | 2021-12-16 | Buy |
TCI Chemical | B4421 | (E)-1,2-Bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene >70.0%(HPLC) | 10mg | $315 | 2023-06-20 | Buy |
Properties
form :powder to crystal
color :Light yellow to Brown
color :Light yellow to Brown
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|